MajesTEC-9 Clinical Trial of Teclistamab in Patients With Multiple Myeloma

MajesTEC-9 Clinical Trial of Teclistamab in Patients With Multiple Myeloma by Madaline Spencer| Published on: Feb 17, 2026 Roberto Mina, MD, Associate Professor at Winship Cancer Institute of Emory University, discusses the Majestec-9 clinical trial of Tecvayli (teclistamab) in patients with multiple myeloma (MM). https://checkrare.com/majestec-9-clinical-trial-of-teclistamab-in-patients-with-multiple-myeloma/